Search
for

    Sort by

    Research 301–330 of 544

    1. Finasteride, dutasteride: potential risk of suicidal ideation Reactions Weekly · 2025
    2. Dipyridamole-Associated Shock and Pulmonary Edema; Oxcarbazepine-Induced Resistant Ventricular Fibrillation; Finasteride-Induced Pseudoporphyria; Suicidal Ideation Associated with Asenapine; Rediscovering Adverse Anticholinergic Effects; Prevalence of Adverse Drug Events in Ambulatory Care Hospital Pharmacy · 2011 · 1 citations
    3. Post-finasteride syndrome: a surmountable challenge for clinicians Fertility and Sterility · 2020 · 30 citations
    4. Risk of Depression Associated With Finasteride Treatment Journal of Clinical Psychopharmacology · 2021 · 7 citations
    5. Ongoing Concerns Regarding Finasteride for the Treatment of Male-Pattern Androgenetic Alopecia JAMA Dermatology · 2020 · 5 citations
    6. 76976 Association of Depression with Finasteride Stratified by Dosage and Diagnosis: A Retrospective Cohort Study Using the TriNetX Database Journal of the American Academy of Dermatology · 2026
    7. Finasteride Use: Evaluation of Depression and Suicide Risk Journal of Cosmetic Dermatology · 2025
    8. Multidimensional assessment of adverse events of finasteride:a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024 medRxiv (Cold Spring Harbor Laboratory) · 2024
    9. Finasteride Reactions Weekly · 2021
    10. Faculty Opinions recommendation of Post-finasteride syndrome: a surmountable challenge for clinicians. Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · 2021
    11. Post-Finasteride Syndrome – When will we Get the Courage to Fight the Dictating Pharma Industry – Despite Awareness of “Sexual, Neurological and Metabolic Side Effects in Young Men for Over a Decade” Archives of urology · 2020
    12. Post-finasteride syndrome: newly recognised condition Reactions Weekly · 2016
    13. Demonstrating the potential of untargeted hair proteomics for personalized biomarkers in stress-associated disorders Psychoneuroendocrinology · 2025
    14. Image3_Neuropsychiatric Adverse Events of Montelukast: An Analysis of Real-World Datasets and drug−gene Interaction Network.TIFF OPAL (Open@LaTrobe) (La Trobe University) · 2021
    15. Mining and analysis of adverse event signals of isotretinoin based on the real-world data of FAERS database Frontiers in Medicine · 2025 · 2 citations
    16. Demonstrating the potential of untargeted hair proteomics for personalized biomarkers in stress-associated disorders medRxiv (Cold Spring Harbor Laboratory) · 2025
    17. Finasteride use and suicide attempts through self-poisoning: A case–control study Clinical and Experimental Dermatology · 2025
    18. Adverse effects of isotretinoin: A retrospective review of 1743 patients started on isotretinoin Australasian Journal of Dermatology · 2010 · 121 citations
    19. French administrative health care database (SNDS): The value of its enrichment Thérapie · 2018 · 64 citations
    20. The Addictive Potential and Challenges with Use of the “Herbal Supplement” Kratom: A Case Report and Literature Review Pain Medicine · 2021 · 19 citations
    21. Psychiatric and sexual dysfunction warnings strengthened for finasteride and dutasteride 2026
    22. ¿Novedad o prudencia? El delicado equilibrio en la actualización farmacológica Actualización en Medicina de Familia · 2025
    23. Is the Safety of Finasteride Correlated With Its Route of Administration: Topical Versus Oral? A Pharmacovigilance Study With Data From the United States Food and Drug Administration Adverse Event Reporting System International Journal of Dermatology · 2025
    24. Deteksi Dini dan Pencegahan Risiko Bunuh Diri pada Remaja Cermin Dunia Kedokteran · 2025
    25. Abstract 4142154: Risk of Suicide, Hair Loss, and Aspiration with Glucagon-like Peptide 1 Receptor Agonists: A Real-World Pharmacovigilance Study from the FAERS database Circulation · 2024
    26. 8679 Case: The Sexual, Physical and Psychological Effects of Post-Finasteride Syndrome Journal of the Endocrine Society · 2024
    27. Sustained hair regrowth with ritlecitinib to Week 48 in patients with alopecia areata: post hoc analysis of the ALLEGRO phase 2b/3 study SKIN The Journal of Cutaneous Medicine · 2023
    28. 448 Challenges of securing insurance approval for oral tofacitinib treatment of alopecia areata: A multi-institutional retrospective review Journal of Investigative Dermatology · 2020
    29. Reporting on Adverse Clinical Events Clin-Alert · 2010
    30. Finasteride: suicidality or psychological adverse events Reactions Weekly · 2020